Foscarnet nephrotoxicity: Mechanism, incidence and prevention

American Journal of Nephrology

Volumn 9, Issue 4, 1989, Pages 316-321

  Deray, Gilbert ^a   Martinez, Franck ^a   Katlama, Christine ^a   Levaltier, Béatrice ^a   Beaufils, Hélène ^b   Danis, Martin ^a   Rozenheim, Michel ^a   Baumelou, Alain ^a   Dohin, Elisabeth ^a   Gentilini, Marc ^a   Jacobs, Claude ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Acute renal failure; CMV infection; Foscarnet; Kidney transplant

Indexed keywords

FOSCARNET;

ADULT; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS; HISTOLOGY; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; ORAL DRUG ADMINISTRATION; VIRUS INFECTION;

ADULT; AGED; COHORT STUDIES; COMPARATIVE STUDY; CREATININE; CYTOMEGALOVIRUS INFECTIONS; FLUID THERAPY; FOSCARNET; HUMAN; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGE; PHOSPHONOACETIC ACID; RETROSPECTIVE STUDIES;

EID: 0024328491     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000167987     Document Type: Article

References (32)

1. Meyers, J.D.; Fluomoy, N.; Thomas, E.D.: Non bacterial pneumonia after allogenic marrow transplantation: a review of ten years’ experience. Rev. infect. Dis. 4: 1119-1132 (1982).
2. Neiman, P.E.; Reeves, W.; Ray, G.; Flournoy, N.; Lernet, K.G.; Sale, G.E.; Thomas, E.D.: A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogenic bone marrow graft. J. infect. Dis. 136: 754-767 (1977).
3. Macher, A.M.; Reichert, C.M.; Strauss, S.E., et al.: Death in the AIDS patient. Role of CMV (Letter). New Engl. J. Med. 309: 1454 (1983).
4. Ch’ien, L.T.; Cannon, N.J.; Whitley, R.J.; Diethelm, A.G.; Dismukes, W.E.; Scott, C.W.; Buchanan, R.A.; Alford, C.A.: Effect of adenine arabinoside on cytomegalovirus infection. J. infect. Dis. 130: 32-39 (1974).
5. Cheesman, S.H.; Rubin, R.H.; Stewart, J.A.; Tolkoff-Rubin, N.E.; Cosimi, A.B.; Cantell, K.; Gilbert, J.; Winkle, S.; Herrin, J.T.; Black, P.H.; Russel, P.S.; Hirsch, M.S.: Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effect of cytomegalovirus and herpes simplex virus infections. New Engl. J. Med. 300: 1345-1349 (1979).
6. Meyers, J.D.; McGuffin, R.W.; Bryson, Y.J.; Cantell, K.; Thomas, E.D.: Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J. infect. Dis. 146: 80-84 (1982).
7. Ashraf, M.H.; Campalani, G.C.; Qureshi, S.A.; Fround, D.J.; Yacoub, M.H.: Acyclovir in the treatment of cytomegalovirus pneumonia after cardiac transplantation. Lancet i: 173-175 (1982).
8. Helgstrand, E.; Eriksson, B.; Johansson, N.G.; Lannero, B.; Larsson, A.; Misiomy, A.; Noren, J.: Phosphanoformate, a new antiviral compound. Science 201: 819-821 (1978).
9. Oberg, B.: Antiviral effects of phosphonoformate (PFA, Foscarnet sodium). Pharmacol. Ther. 19: 387-415 (1983).
10. Sundquist, B.; Oberg, B.: Phosphonoformate inhibits reverse transcriptase. J. gen. Virol. 45: 273-281 (1979).
11. Sandstrom, E.G.; Kaplan, J.C.; Byingtn, R.E.; Hirsch, M.S.: Inhibition of human T-cell lymphotrophic virus type III in vitro by phosphonoformate. Lancet i: 1480-1482 (1985).
12. Ringden, O.; Lonnquist, B.; Paulin, T.; Ahlmen, J.; Klintmaln, G.; Wahren, B.; Lemestedt, J.O.: Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. J. antimicrol. Chemother. 17: 373-387 (1986).
13. Akesson, A.; Lenestedt, J.O.; Ringden, O.; Lonnqvist, B.; Wahren, B.: Sensitivity of cytomegalovirus to intravenous foscamet treatment. Bone Marrow Transplant. 1: 1-6 (1986).
14. Weber, J.N.; Thom, S.; Barrison, I.; Unrwin, R.; Forster, S.; Jeffries, D.J.; Boylston, A.; Pinghing, A.J.: Cytomegalovirus colitis and oesophagal ulcerations in the context of AIDS: clinical manifestations and preliminary report of treatment with foscamet (phosphonoformate). Gut 28: 482-487 (1987).
15. Farthing, C.F.; Dalgleish, A.G.; Clark, A.; McClure, M.; Chanas, A.; Gazzard, B.G.: Phosphonoformate (Foscamet): a pilot study in AIDS and AIDS related complex. AIDS 1: 21-25 (1987).
16. Gaub, J.; Pedersen, C.; Penisen, A.G.; Mathiesen, L.R.; Ulrich, K.; Lindhardt, B.O.; Faber, V.; Gerstoft, J.; Hofmann, B.; Lernestedt, J.O.; Nielsen, C.M.; Nielsen, J.O.; Platz, P.: The effect of Foscamet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients. AIDS 1:27-33 (1987).
17. Cacoub, P.; Deray, G.; Baumelou, A.; Le Hoang, P.; Rozenbaum, W.; Gentilini, M.; Soubrie, C.; Rousselie, F.; Jacobs, C.: Acute renal failure induced by Foscamet. 4 cases. Clin. Nephrol, (in press).
18. Deray, G.; Cacoub, P.; Le Hoang, P.; Baumelou, A.; Soubrie, C.; Rousselie, F.; Morer, I.; Jacobs, C.: Foscamet induced acute renal failure and effectiveness of haemodialysis (Letter). Lancet ii: 216 (1987).
19. Klintmalm, G.; Lonnqvist, B.; Oberg, B.O.; Gahrton, G.; Lernestedt, J.O.; Lundgren, G.; Ringden, O.; Robert, K.H.; Wahren, B.; Groth, C.G.: Intravenous foscamet for the treatment of severe cytomegalovirus infection in allograft recipient. Scand. J. infect. Dis. 17: 157-163 (1985).
20. Hayes, D.M.; Cvitkovic, E.; Golbey, R.B.; Scheiner, E.; Helson, L.; Krakoff, I.: High dose cis-platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 39: 1372-1381 (1987).
21. Bailey, R.R.; Natale, R.; Turnbull, I.; Linton, A.L.: Protective effect of furosemide in acute tubular necrosis and acute renal failure. Clin. Sei. 45: 1-10 (1983).
22. Lee, M.S.; Hillman, B.J.; Clark, R.L.; Ulrich, R.M.: The effects of diltiazem and captopril on glycerol induced acute renal failure in the rat. Investve Radiol. 20: 961-968 (1983).
23. Wagner, K.; Neumayer, H.K.: Prevention of delayed graft function in cadaver kidney transplants by diltiazem. Lancet ii: 13-55 (1985).
24. Hsuc, H.; Kurtz, I.W.; Weller, J.M.: The role of tubular necrosis in the pathophysiology of acute renal failure. Nephron 17:204-214 (1976).
25. Thurau, K.: Modification of angiotensin mediated tubulo-glomerular feedback by extracellular volume. Kidney int. 8: S202-S207 (1975).
26. Wright, F.S.; Schermann, J.: Interference with feedback control of glomerular filtration rate by furosemide, triflocin and cyanide. J. clin. Invest. 53: 1695-1708 (1984).
27. Hofbauer, K.G.; Konrads, A.; Bauereiss, K.; Mohring, B.; Mohring, J.; Gross, F.: Vasopressin and renin in glycerol induced acute renal failure in the rat. Circulation Res. 41: 424-428 (1977).
28. Flamenbaum, W.; Kotchen, T.A.; Nagle, R.; McNeil, J.S.: Effect of potassium on the renin angiotensin system and HgChinduced acute renal failure. Am. J. Physiol. 224: 305-311 (1973).
29. Bidani, A.; Churchill, P.; Fleischman, L.: Sodium-chlorideinduced protection in nephrotoxic acute renal failure. Independence from renin. Kidney int. 16: 481-490 (1979).
30. Einhorn, L.H.; Donahue, J.: Cis-diammine dichloroplatinum vinblastine and bloomycine combination chemotherapy in disseminated testicular cancer. Ann. intern. Med. 87: 293-298 (1977).
31. Glode, L.M.; Pitman, S.W.; Ensminger, W.D.; Rosowsky, A.; Papathanasopoules, N.; Frei, E.: A phase I study of high doses of aminopterin with leucovorin rescue in patients with advanced metastatic tumors. Cancer Res. 39: 3707-3714 (1979).
32. Pitman, S.W.; Frei, E.: Weekly methotrexate-calcium leucovorin rescue. Effect of alkalinization on nephrotoxicity pharmacokinetics in the CNS, and use in CNS non-Hodgkins lymphoma. Cancer Treat. Reg. 61: 695-702 (1977)